Type to search

Enhertu Approved in the US for Patients with HER2-positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-based Regimen | Pharmtech Focus
Calquence Demonstrated Fewer Incidences of Atrial Fibrillation Versus Ibrutinib in Previously Treated Patients with Chronic Lymphocytic Leukaemia | Pharmtech Focus
Tagrisso Approved in the EU for the Adjuvant Treatment of Patients with Early-stage EGFR-mutated Lung Cancer | Pharmtech Focus